Bio-Rad Laboratories BIO Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
Plus components not separately reported this period.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's total debt?
- Bio-Rad Laboratories (BIO) reported total debt of $987.3M in Q1 2026.
- How has Bio-Rad Laboratories's total debt changed year-over-year?
- Bio-Rad Laboratories's total debt decreased by 28.4% year-over-year, from $1.38B to $987.3M.
- What is the long-term trend for Bio-Rad Laboratories's total debt?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's total debt has grown at a 42.7% compound annual growth rate (CAGR), from $235.86M to $1.39B.
- What does total debt mean?
- The total amount of money a company owes to lenders and creditors through loans, bonds, and lease obligations.
- How do you interpret total debt?
- An increase in total debt suggests higher financial leverage and increased interest expense, which may heighten financial risk, while a decrease indicates deleveraging and potentially improved balance sheet health.
- How does total debt compare across companies?
- Peers in the life sciences and clinical diagnostics sectors typically maintain debt levels relative to their EBITDA to ensure creditworthiness and flexibility for R&D or M&A activities.